Biocon Declines Over 3% After Net Profit Rose 105% In March Quarter
Biocon Share Price Today: On Friday, Biocon opened on the BSE at Rs 392, touching an intra day high of Rs 392 and an intra day low of Rs 380.55, in the trading session so far.
BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Dividend Updates
Update on declaration of dividend for FY21 Earnings Call for Q4FY21 of Biocon
Conference Call with Biocon Management and Analysts on Q4FY21 Performance and Outlook. Watch the full earnings transcript. Management in attendance: Kiran Mazumdar Shaw Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Allotment
Allotment of equity shares to Biocon India Limited Employee Welfare Trust under Biocon Restricted Stock Unit Long Term Incentive Plan FY 2020-24. Biocon Ltd - 532523 - Change In Key Managerial Personnel Of The Company
Change in Key Managerial Personnel of the Company Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Biocon Q4FY21 Revenue at Rs 2,044 Cr, Up 26%; EBITDA at Rs 641 Cr; Up 68% Net Profit (before exceptional item & discontinuing operations) at Rs 257 Cr; Biosimilars Up 53% at Rs 664Cr; Research Services Up 8% at Rs 659 Cr; Generics Up 3% at Rs 578 Cr., FY21 Revenue Up 14% at Rs 7,360 Cr; EBITDA Up 8% at Rs 1,907 Cr; Net Profit (before exceptional item & discontinuing operations) at Rs 754 Cr. BIOCON LTD. - 532523 - Outcome Of Board Meeting - Financial Results
Financial results for the quarter and year ended March 31, 2021. Biocon Ltd - 532523 - Audited Financial Results For The Quarter And Year Ended March 31, 2021.
Approved audited financial results (consolidated and standalone) as per Indian Accounting Standard (Ind-AS) along with Auditors' Report for the quarter and year ended March 31, 2021. A copy of the audited financial results along with the Auditors' Report and a declaration under Regulation 33(3)(d) of SEBI Listing Regulations are enclosed herewith. BIOCON LTD. - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Biocon Biologics' New Monoclonal Antibodies Manufacturing Facility Wins ISPE's 2021 Facility of the Year Honorable Mention Award